Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Gynecologic 1CNS 1

Conditions

Sarcoma 36Glioblastoma 10Breast Neoplasms 9Osteosarcoma 8Melanoma 8Gliosarcoma 8Bone Neoplasms 7Stomach Neoplasms 6Pancreatic Neoplasms 6Ovarian Neoplasms 6Lung Neoplasms 6Head and Neck Neoplasms 6Squamous Cell Carcinoma of Head and Neck 5Sarcoma, Alveolar Soft Part 4Lymphoma 4Colorectal Neoplasms 4Colonic Neoplasms 4Brain Neoplasms 4Rhabdomyosarcoma 3Rectal Neoplasms 3Oligodendroglioma 3Neoplasms 3Liver Neoplasms 3Gastrointestinal Neoplasms 3Desmoplastic Small Round Cell Tumor 3Dendritic Cell Sarcoma, Interdigitating 3Astrocytoma 3Small Cell Lung Carcinoma 2Sarcoma, Synovial 2Sarcoma, Kaposi 2

Interventions

montelukast 1Tablets 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Inflammation × Sarcoma × Clear all
NCT06887673 2025-03-20

Lipid Mediators & Cancer: Montelukast, SPM, and Almonds

University of South Florida

Phase EARLY_PHASE1 Not yet recruiting
56 enrolled
CNSGastrointestinalGynecologicSarcoma

Brain Neoplasms, Inflammation, Ovarian Neoplasms, Sarcoma, Colorectal Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡